The information on this page about Danavir-R 600 Tablet – Darunavir 600 mg + Ritonavir 100 mg is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Danavir-R 600 Tablet is a prescription-only antiretroviral medicine used as part of doctor-prescribed HIV treatment (ART) for HIV-1 infection and must be taken only under the supervision of a qualified healthcare professional. Do not self-medicate, change the dose, skip doses, or stop treatment without medical advice.
Always inform your doctor about your medical history, liver conditions, kidney conditions, allergies (including any sulfonamide/sulfa allergy), and all medicines or supplements you take, as Ritonavir can interact with many drugs. Danavir-R 600 Tablet does not cure HIV/AIDS and should be used with regular medical follow-ups and monitoring as advised by your doctor.
Medically reviewed by qualified clinicians at TAAL+ Healthcare. Last reviewed: June 2026.

This page has been medically reviewed by TAAL+ Healthcare Specialist Doctors, including professionals experienced in HIV medicine, infectious diseases, sexual wellness, preventive care, and long-term patient management.
Our clinical review process helps ensure that the medical information on this page is reviewed for accuracy, patient relevance, and alignment with current HIV treatment and ART care practices.
Clinical Areas: HIV Treatment (ART), PrEP, PEP, STI & STD Care, Sexual Wellness, Mental Health Support
Last Updated: June 2026
Danavir-R 600 Tablet is a Schedule H prescription-only antiretroviral medicine containing Darunavir 600 mg + Ritonavir 100 mg, used as part of combination antiretroviral therapy (ART) for HIV-1 infection. Because boosted protease-inhibitor therapy involves important drug interactions and regular treatment monitoring, it should only be taken under medical supervision and exactly as prescribed by your doctor.